Publications by authors named "W J Britton"

Within mindfulness-based programs (MBPs), mixed results have been found for the role of childhood trauma as a moderator of depression outcomes. Furthermore, childhood trauma and PTSD symptoms have been identified as possible risk factors for the occurrence of meditation-related adverse effects (MRAE). The present research examined multiple forms of childhood trauma and PTSD symptoms as predictors of depression treatment outcomes and MRAEs.

View Article and Find Full Text PDF

Multi-drug-resistant Mycobacterium tuberculosis is an escalating global health problem, and a strong pipeline of novel compounds is needed to combat rising antimicrobial resistance. Ecumicin is a novel analogue of the natural antimycobacterial cyclic peptide ecumicin, with selective activity against Mycobacterium species. The activity of ecumicin∗ was compared to that of frontline tuberculosis therapies under in vitro conditions representative of niches where M.

View Article and Find Full Text PDF

The rufomycins are a family of nonribosomal cyclic peptides isolated from the deep sea-dwelling Herein, we describe the total synthesis of six congeners in the rufomycin family. Synthesis was achieved through a modular solid-phase strategy, incorporating synthetic nonproteinogenic amino acids: l-2-amino-4-hexenoic acid, prenyl-l-tryptophan (and related ()-epoxide), and -methyl-δ-hydroxy-l-leucine. Following macrolactamization, these peptides were further diversified through late-stage oxidation and secondary cyclization to furnish a library of six synthetic natural products.

View Article and Find Full Text PDF

Background: Current literature informs us that bivalent vaccines will generate a broader serum neutralizing antibody response to multiple SARS-CoV-2 variants, but studies on how this breadth relates to the memory B cell (MBC) and T cell responses are sparse. This study compared breadth of neutralising antibody, and memory B and T cell responses to monovalent or a bivalent ancestral/Omicron BA.1 COVID-19 booster vaccine.

View Article and Find Full Text PDF
Article Synopsis
  • Tuberculosis (TB) is a significant global health issue, and repurposing existing antimicrobial drugs could enhance treatment options, specifically through the use of beta-lactams in conjunction with beta-lactamase inhibitors.* -
  • This study tested seven beta-lactams and two inhibitors for their effectiveness against Mycobacterium tuberculosis and identified that clavulanate significantly boosted the beta-lactam activity compared to avibactam, leading to avibactam's exclusion from further tests.* -
  • The research found various combinations of beta-lactams that worked synergistically with clavulanate, while most combinations with second-line TB drugs like moxifloxacin showed negative interactions, highlighting the importance of careful drug pairing
View Article and Find Full Text PDF